Literature DB >> 29167277

Aging-Related Disease Risks among Young Thyroid Cancer Survivors.

Brenna E Blackburn1,2, Patricia A Ganz3, Kerry Rowe4, John Snyder4, Yuan Wan5, Vikrant Deshmukh6, Michael Newman1,6, Alison Fraser5, Ken Smith5, Kimberly Herget7, Jaewhan Kim8, Anne C Kirchhoff2,9, Christina Porucznik1, Heidi Hanson1,5, Marcus Monroe2,10, Mia Hashibe11,2.   

Abstract

Background: Thyroid cancer is the most rapidly increasing cancer in the United States, affects a young population, has high survival, and is one of the most common cancers in people under age 40. The aim of this study was to examine the risks of aging-related diseases in a statewide sample of thyroid cancer survivors who were diagnosed <40 years compared with those diagnosed ≥40 and a cancer-free sample.
Methods: Thyroid cancer survivors diagnosed 1997 to 2012 were matched to up to 5 cancer-free individuals on birth year, sex, birth state, using the statewide Utah Population Database. Medical records were used to identify disease diagnoses stratified over three time periods: 1 to 5, >5 to 10, and 10+ years after cancer diagnosis. Cox proportional hazards models were used to estimate hazard ratios with adjustment on matching factors, race, body mass index, and Charlson Comorbidity Index.
Results: There were 3,706 thyroid cancer survivors and 15,587 matched cancer-free individuals (1,365 cases diagnosed <40 years old). Both age groups had increased risks for multiple circulatory health conditions 1 to 5 years after cancer diagnosis compared with cancer-free individuals. Survivors <40 had a higher risk of hypertension, cardiomyopathy, and nutritional deficiencies.Conclusions: Increased risks for diseases associated with aging were observed for both age groups, with younger thyroid cancer survivors having higher risks for select diseases.Impact: As thyroid cancer survivors in this study were found to have increased risks for aging-related diseases, future studies are needed to assess what can be done to reduce the increased risks of these long-term health effects. Cancer Epidemiol Biomarkers Prev; 26(12); 1695-704. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2017        PMID: 29167277      PMCID: PMC5903447          DOI: 10.1158/1055-9965.EPI-17-0623

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  30 in total

Review 1.  Late effects of cancer and its treatment.

Authors:  P A Ganz
Journal:  Semin Oncol Nurs       Date:  2001-11       Impact factor: 2.315

2.  Cancer-related worry in Canadian thyroid cancer survivors.

Authors:  Lauren Bresner; Rita Banach; Gary Rodin; Lehana Thabane; Shereen Ezzat; Anna M Sawka
Journal:  J Clin Endocrinol Metab       Date:  2014-11-13       Impact factor: 5.958

Review 3.  Cancer Treatment as an Accelerated Aging Process: Assessment, Biomarkers, and Interventions.

Authors:  Arti Hurria; Lee Jones; Hyman B Muss
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

4.  Long-term thyrotropin-suppressive therapy with levothyroxine impairs small and large artery elasticity and increases left ventricular mass in patients with thyroid carcinoma.

Authors:  M Shargorodsky; S Serov; D Gavish; E Leibovitz; D Harpaz; R Zimlichman
Journal:  Thyroid       Date:  2006-04       Impact factor: 6.568

5.  Initial treatment patterns in younger adult patients with differentiated thyroid cancer in California.

Authors:  Thomas J Semrad; Alison M Semrad; D Gregory Farwell; Yingjia Chen; Rosemary Cress
Journal:  Thyroid       Date:  2015-03-23       Impact factor: 6.568

6.  Effect of postoperative thyrotropin suppressive therapy on bone mineral density in patients with papillary thyroid carcinoma: a prospective controlled study.

Authors:  Iwao Sugitani; Yoshihide Fujimoto
Journal:  Surgery       Date:  2011-12       Impact factor: 3.982

7.  Health profiles in 5836 long-term cancer survivors.

Authors:  Pamela N Schultz; Martha L Beck; Charles Stava; Rena Vassilopoulou-Sellin
Journal:  Int J Cancer       Date:  2003-04-20       Impact factor: 7.396

8.  Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.

Authors:  Shin Young Jeong; Hae Won Kim; Sang-Woo Lee; Byeong-Cheol Ahn; Jaetae Lee
Journal:  Thyroid       Date:  2013-04-18       Impact factor: 6.568

9.  Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme.

Authors:  Eva-Maria Gamper; Lisa M Wintner; Margarida Rodrigues; Sabine Buxbaum; Bernhard Nilica; Susanne Singer; Johannes M Giesinger; Bernhard Holzner; Irene Virgolini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-13       Impact factor: 9.236

10.  The cost of cancer: a retrospective analysis of the financial impact of cancer on young adults.

Authors:  Michelle S Landwehr; Samantha E Watson; Catherine F Macpherson; Katherine A Novak; Rebecca H Johnson
Journal:  Cancer Med       Date:  2016-02-07       Impact factor: 4.452

View more
  10 in total

1.  Risk Factors for Cardiovascular Disease Among Thyroid Cancer Survivors: Findings From the Utah Cancer Survivors Study.

Authors:  Jihye Park; Brenna E Blackburn; Patricia A Ganz; Kerry Rowe; John Snyder; Yuan Wan; Vikrant Deshmukh; Michael Newman; Alison Fraser; Ken Smith; Kim Herget; Anne C Kirchhoff; Dev Abraham; Jaewhan Kim; Marcus Monroe; Mia Hashibe
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

2.  Analyses of the Association between Thyroid Cancer and Osteoporosis/Fracture Histories: A Cross-Sectional Study Using KoGES HEXA Data.

Authors:  Young-Ju Jin; Chang-Myeon Song; Bum-Jung Park; Hyo-Geun Choi
Journal:  Int J Environ Res Public Health       Date:  2021-04-29       Impact factor: 3.390

3.  Influence of Socioeconomic Status on Incident Medical Conditions in Two-Year Survivors of Adolescent or Young Adult Differentiated Thyroid Cancer.

Authors:  Thomas J Semrad; Qian Li; Melanie Goldfarb; Alison Semrad; Michael Campbell; D Gregory Farwell; Theresa H M Keegan
Journal:  J Adolesc Young Adult Oncol       Date:  2021-01-28       Impact factor: 1.757

Review 4.  Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis.

Authors:  Keyi Yang; Zhunzhun Liu; Melissa S Y Thong; Daniela Doege; Volker Arndt
Journal:  Cancers (Basel)       Date:  2022-04-02       Impact factor: 6.639

5.  Long-term cardiovascular and cerebrovascular morbidity in Israeli thyroid cancer survivors.

Authors:  Elena Izkhakov; Joseph Meyerovitch; Micha Barchana; Yacov Shacham; Naftali Stern; Lital Keinan-Boker
Journal:  Endocr Connect       Date:  2019-04       Impact factor: 3.335

6.  Risk of Osteoporosis and Fractures in Patients with Thyroid Cancer: A Case-Control Study in U.S. Veterans.

Authors:  Maria Papaleontiou; Mousumi Banerjee; David Reyes-Gastelum; Sarah T Hawley; Megan R Haymart
Journal:  Oncologist       Date:  2019-06-04

7.  Are We Missing the Elephant in the Room? A Case for Thyroid Cancer Overdiagnosis As the Etiology for Its Increasing Incidence in India.

Authors:  Janeesh Sekkath Veedu; Aju Mathew
Journal:  J Glob Oncol       Date:  2018-10

8.  Factors affecting the health-promoting behavior of thyroid cancer survivors: comparison by stage of cancer survivorship.

Authors:  Kyung Ah Park; Sanghee Kim; Eui Geum Oh; Heejung Kim; Hang-Seok Chang; Soo Hyun Kim
Journal:  Support Care Cancer       Date:  2022-01-08       Impact factor: 3.359

9.  Quality of Life of Survivors of Thyroid Cancer Is Not Inferior to That in Subjects without Cancer: Long-Term after Over 5 Years.

Authors:  Jeongmin Lee; Youn-Ju Lee; Dong-Jun Lim; Jung-Min Lee; Sang-Ah Chang; Min-Hee Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2022-08-29

10.  Cardiovascular disease risks in younger versus older adult B-cell non-Hodgkin's lymphoma survivors.

Authors:  Krista Ocier; Sarah Abdelaziz; Seungmin Kim; Kerry Rowe; John Snyder; Vikrant Deshmukh; Michael Newman; Alison Fraser; Ken Smith; Christina A Porucznik; Kimberley Shoaf; Joseph B Stanford; Catherine J Lee; Mia Hashibe
Journal:  Cancer Med       Date:  2021-05-12       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.